(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are XILAM ANIMATION, FLUTTER ENTERTAIN, and MKB Nedsense.

Financial Asset	Price	Change	Updated (EST)
XILAM ANIMATION (XIL.PA)	5.48	17.09%	2024-01-18 13:24:51
FLUTTER ENTERTAIN (FLTR.IR)	175.60	14.1%	2024-01-18 12:22:50
MKB Nedsense (NEDSE.AS)	0.10	12.35%	2024-01-18 12:02:57
RALLYE (RAL.PA)	0.13	10.15%	2024-01-18 13:21:43
FUT.CLUBE PORTO (FCP.LS)	1.30	8.33%	2024-01-18 12:23:33
ALUMEXX N.V. (ALX.AS)	1.08	8%	2024-01-18 12:00:27
FERMENTALG (FALG.PA)	0.29	7.55%	2024-01-18 13:03:18
ADOCIA (ADOC.PA)	10.82	7.13%	2024-01-18 12:44:55
MEMSCAP REGPT (MEMS.PA)	7.08	5.99%	2024-01-18 13:20:14
POLIGHT (PLT.OL)	23.00	5.5%	2024-01-18 12:42:20

The three biggest losers today are ONWARD MEDICAL, ATOS, and AUREA.

Financial Asset	Price	Change	Updated (EST)
ONWARD MEDICAL (ONWD.BR)	2.23	-10.08%	2024-01-18 12:20:57
ATOS (ATO.PA)	3.76	-9.77%	2024-01-18 12:45:54
AUREA (AURE.PA)	4.65	-8.82%	2024-01-18 12:46:00
KENMARE RESOURCES (KMR.IR)	3.92	-5.77%	2024-01-18 12:23:03
SEQUANA MEDICAL (SEQUA.BR)	2.83	-5.67%	2024-01-18 12:21:41
GLINTT (GLINT.LS)	0.34	-5.49%	2024-01-18 12:23:37
AUGROS COSMETICS (AUGR.PA)	7.00	-5.41%	2024-01-18 12:45:58
CARASENT (CARA.OL)	12.28	-5.39%	2024-01-18 12:25:43
ITERA (ITERA.OL)	12.60	-5.26%	2024-01-18 12:40:38
POXEL (POXEL.PA)	0.42	-4.82%	2024-01-18 13:21:32

Winners today

1. XILAM ANIMATION (XIL.PA)

17.09% Price Change

Xilam Animation operates as an audiovisual production company in France and internationally. The company creates, produces, and distributes original programs for children and adults. It also broadcasts content on television; subscription video on demand streaming platforms, including Netflix, Disney +, Amazon, and NBC Universal; and advertising video on demand streaming platforms, such as YouTube and Facebook. In addition, the company produces animated, series, mini-series, and feature films. It owns the Oggy, Cockroaches, Zig & Sharko, Chicky, Oggy Oggy in preschool, Oggy Next Gen, Les Tales of Lupin, Moka, Mr Magoo, Trico, and I Lost My Body brands. The company was incorporated in 1999 and is headquartered in Paris, France.

CAC 40 ended the session with XILAM ANIMATION rising 17.09% to €5.48 on Thursday while CAC 40 rose 1.13% to €7,401.35.

Earnings Per Share

As for profitability, XILAM ANIMATION has a trailing twelve months EPS of €0.08.

PE Ratio

XILAM ANIMATION has a trailing twelve months price to earnings ratio of 68.5. Meaning, the purchaser of the share is investing €68.5 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.96%.

Volatility

XILAM ANIMATION’s last week, last month’s, and last quarter’s current intraday variation average was 4.60%, 1.32%, and 3.06%.

XILAM ANIMATION’s highest amplitude of average volatility was 5.25% (last week), 3.03% (last month), and 3.06% (last quarter).

More news about XILAM ANIMATION.

2. FLUTTER ENTERTAIN (FLTR.IR)

14.1% Price Change

Flutter Entertainment plc operates as a sports betting and gaming company in the United Kingdom, Ireland, Australia, the United States, and internationally. The company operates through four segments: UK & Ireland, Australia, International, and US. It offers sportsbooks and exchange sports betting products, daily fantasy sports products, and pari-mutuel betting products; fixed odds games betting products; online games and casinos; lottery; peer-to-peer games, including online bingo, rummy, and poker; and business-to-business services. In addition, the company operates HRTV, a horseracing television network. Further, it provides sports betting and gaming services through paddypower.com, betfair.com, sportsbet.com.au, tvg.com, us.betfair.com, fanduel.com, adjarabet.com, pokerstars.com, Skybet.com, tombola.com, and sisal.com websites under the FanDuel, Sky Betting & Gaming, Sportsbet, PokerStars, Paddy Power, Sisal, tombola, Betfair, FOX Bet, TVG, Stardust, Junglee Games, and Adjarabet brands, as well as live poker tours and events. The company was formerly known as Paddy Power Betfair plc and changed its name to Flutter Entertainment plc in 2019. The company was incorporated in 1958 and is headquartered in Dublin, Ireland.

ISEQ All Share ended the session with FLUTTER ENTERTAIN rising 14.1% to €175.60 on Thursday, following the last session’s downward trend. ISEQ All Share jumped 3.86% to €8,796.60, after two consecutive sessions in a row of losses, on what was a very positive trend trading session today.

Earnings Per Share

As for profitability, FLUTTER ENTERTAIN has a trailing twelve months EPS of €-0.38.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.63%.

More news about FLUTTER ENTERTAIN.

3. MKB Nedsense (NEDSE.AS)

12.35% Price Change

MKB Nedsense N.V. engages in the finance and lending of money to natural persons and legal entities. It also provides guarantees and/or other securities towards third parties for its obligations and/or for obligations for companies in the investment portfolio. The company was formerly known as Nedsense Enterprises N.V. MKB Nedsense N.V. was founded in 1999 and is based in Bussum, the Netherlands.

AEX-Index ended the session with MKB Nedsense rising 12.35% to €0.10 on Thursday, after four consecutive sessions in a row of losses. AEX-Index rose 0.87% to €778.17, after three sequential sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.08%.

Volatility

MKB Nedsense’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.32%, a negative 4.35%, and a positive 5.16%.

MKB Nedsense’s highest amplitude of average volatility was 2.32% (last week), 7.42% (last month), and 5.16% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 91.1%, now sitting on -50k for the twelve trailing months.

Volume

Today’s last reported volume for MKB Nedsense is 6143 which is 93.16% below its average volume of 89921.

Moving Average

MKB Nedsense’s value is way higher than its 50-day moving average of €0.09 and way higher than its 200-day moving average of €0.09.

More news about MKB Nedsense.

4. RALLYE (RAL.PA)

10.15% Price Change

Rallye SA, together with its subsidiaries, engages in the food and non-food e-commerce retailing business in France and internationally. The company operates in two segments, Food and General Retailing, and Holdings and Other Activities. It operates hypermarkets, supermarkets, and convenience stores. The company conducts its retailing activities in France primarily under the Casino, Monoprix, and Franprix banners; food retail activities in Brazil, Colombia, Uruguay, and Argentina mainly under the GPA food banners, Éxito, Disco-Devoto, and Libertad banners; and e-commerce comprising Cdiscount and the Cnova N.V. holding company businesses. It is also involved in the financial investment, property development, and energy related activities. The company was founded in 1925 and is headquartered in Paris, France. Rallye SA operates as a subsidiary of Foncière Euris SA.

CAC 40 ended the session with RALLYE rising 10.15% to €0.13 on Thursday, following the last session’s upward trend. CAC 40 jumped 1.13% to €7,401.35, after three successive sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, RALLYE has a trailing twelve months EPS of €-12.91.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -71.26%.

Yearly Top and Bottom Value

RALLYE’s stock is valued at €0.13 at 21:40 EST, way below its 52-week high of €3.10 and way above its 52-week low of €0.03.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, RALLYE’s stock is considered to be overbought (>=80).

More news about RALLYE.

5. FUT.CLUBE PORTO (FCP.LS)

8.33% Price Change

Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.

PSI ended the session with FUT.CLUBE PORTO rising 8.33% to €1.30 on Thursday while PSI dropped 0% to €6,322.62.

Earnings Per Share

As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €0.94.

PE Ratio

FUT.CLUBE PORTO has a trailing twelve months price to earnings ratio of 1.38. Meaning, the purchaser of the share is investing €1.38 for every euro of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth grew by 13.3%, now sitting on 155.82M for the twelve trailing months.

Volatility

FUT.CLUBE PORTO’s last week, last month’s, and last quarter’s current intraday variation average was 5.26%, 0.56%, and 7.20%.

FUT.CLUBE PORTO’s highest amplitude of average volatility was 5.26% (last week), 7.03% (last month), and 7.20% (last quarter).

Yearly Top and Bottom Value

FUT.CLUBE PORTO’s stock is valued at €1.30 at 21:40 EST, higher than its 52-week high of €1.24.

Moving Average

FUT.CLUBE PORTO’s worth is way above its 50-day moving average of €1.11 and way above its 200-day moving average of €1.04.

More news about FUT.CLUBE PORTO.

6. ALUMEXX N.V. (ALX.AS)

8% Price Change

Alumexx N.V. manufactures and sells scaffoldings, stairs, ladders, accessories, and tools for indoor or outdoor use in the Netherlands and internationally. The company was formerly known as Phelix N.V. and changed its name to Alumexx N.V. in January 2018. Alumexx N.V. was founded in 1991 and is based in Etten-Leur, the Netherlands.

AEX-Index ended the session with ALUMEXX N.V. rising 8% to €1.08 on Thursday, after five sequential sessions in a row of losses. AEX-Index rose 0.87% to €778.17, after three successive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, ALUMEXX N.V. has a trailing twelve months EPS of €0.12.

PE Ratio

ALUMEXX N.V. has a trailing twelve months price to earnings ratio of 9. Meaning, the purchaser of the share is investing €9 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.26%.

Volatility

ALUMEXX N.V.’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.70%, a positive 2.52%, and a positive 3.97%.

ALUMEXX N.V.’s highest amplitude of average volatility was 4.70% (last week), 6.85% (last month), and 3.97% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ALUMEXX N.V.’s stock is considered to be overbought (>=80).

More news about ALUMEXX N.V..

7. FERMENTALG (FALG.PA)

7.55% Price Change

Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.

CAC 40 ended the session with FERMENTALG jumping 7.55% to €0.29 on Thursday, after five sequential sessions in a row of losses. CAC 40 jumped 1.13% to €7,401.35, after three consecutive sessions in a row of losses, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.52%.

More news about FERMENTALG.

8. ADOCIA (ADOC.PA)

7.13% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA jumping 7.13% to €10.82 on Thursday while CAC 40 rose 1.13% to €7,401.35.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-2.5.

Volume

Today’s last reported volume for ADOCIA is 122271 which is 31.58% below its average volume of 178726.

Volatility

ADOCIA’s last week, last month’s, and last quarter’s current intraday variation average was 0.89%, 1.14%, and 3.78%.

ADOCIA’s highest amplitude of average volatility was 1.24% (last week), 4.78% (last month), and 3.78% (last quarter).

Moving Average

ADOCIA’s value is way higher than its 50-day moving average of €9.07 and way higher than its 200-day moving average of €6.63.

Revenue Growth

Year-on-year quarterly revenue growth declined by 62.6%, now sitting on 10.84M for the twelve trailing months.

More news about ADOCIA.

9. MEMSCAP REGPT (MEMS.PA)

5.99% Price Change

MEMSCAP, S.A. provides micro-electro-mechanical systems (MEMS) based solutions for aerospace and defense, optical communications, medical, and biomedical markets worldwide. The company offers pressure sensors, pressure transducers, and pressure switches for various applications, such as air data computers, cabin pressure, engine control, altimeters, barometers, cockpit instruments, and air data test sets. It also provides gold coated and titanium-based pressure transducers, plastic domes, line-sets, and related accessories. In addition, the company supplies optical MEMS chips for variable optical attenuators in optical telecommunication markets; and provides the multi-user MEMS processes. Further, it offers mounting brackets, snap holders, non-sterile and sterile domes, and monitoring line sets. MEMSCAP, S.A. was founded in 1997 and is based in Crolles, France.

CAC 40 ended the session with MEMSCAP REGPT rising 5.99% to €7.08 on Thursday while CAC 40 rose 1.13% to €7,401.35.

Earnings Per Share

As for profitability, MEMSCAP REGPT has a trailing twelve months EPS of €0.15.

PE Ratio

MEMSCAP REGPT has a trailing twelve months price to earnings ratio of 47.2. Meaning, the purchaser of the share is investing €47.2 for every euro of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth grew by 43.4%, now sitting on 12.8M for the twelve trailing months.

Volatility

MEMSCAP REGPT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.44%, a positive 0.22%, and a positive 3.31%.

MEMSCAP REGPT’s highest amplitude of average volatility was 3.08% (last week), 3.26% (last month), and 3.31% (last quarter).

Volume

Today’s last reported volume for MEMSCAP REGPT is 21178 which is 49.17% below its average volume of 41670.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MEMSCAP REGPT’s stock is considered to be overbought (>=80).

More news about MEMSCAP REGPT.

10. POLIGHT (PLT.OL)

5.5% Price Change

poLight ASA develops optical lens for consumer devices and industrial applications in Europe, Asia, and the United States. The company's lens replicates the lens of the human eye enabling the implementation of autofocus functions for various applications. Its product portfolio includes TLens, a tuneable optical lens for autofocus camera applications; Packaged TLens that facilitates integration of a TLens on a fixed-focus camera module; ASIC drivers, which control the supply of variable voltage to Tlens products and makes them to change focus; TLens Silver and TLens Silver Premium devices; and evaluation kits that allows to test and evaluate the optical and electrical performance of the TLens in new products and/or applications. it serves smartphones and wearables, barcode/industrial, augmented reality, medical endoscopy, webcams, and other markets. poLight ASA was founded in 2005 and is headquartered in Skoppum, Norway.

Oslo Børs Benchmark Index_GI ended the session with POLIGHT rising 5.5% to €23.00 on Thursday while Oslo Børs Benchmark Index_GI jumped 0.41% to €1,276.39.

Earnings Per Share

As for profitability, POLIGHT has a trailing twelve months EPS of kr-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.27%.

Yearly Top and Bottom Value

POLIGHT’s stock is valued at kr23.00 at 21:40 EST, way under its 52-week high of kr29.00 and way above its 52-week low of kr9.80.

More news about POLIGHT.

Losers Today

1. ONWARD MEDICAL (ONWD.BR)

-10.08% Price Change

Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARC-EX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation to treat upper extremity functional deficits with chronic tetraplegia. The company was founded in 2014 and is headquartered in Eindhoven, Netherlands.

BEL 20 ended the session with ONWARD MEDICAL dropping 10.08% to €2.23 on Thursday while BEL 20 fell 0.44% to €3,552.84.

Earnings Per Share

As for profitability, ONWARD MEDICAL has a trailing twelve months EPS of €-1.2.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -69.93%.

More news about ONWARD MEDICAL.

2. ATOS (ATO.PA)

-9.77% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS sliding 9.77% to €3.76 on Thursday while CAC 40 jumped 1.13% to €7,401.35.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-10.01.

Volume

Today’s last reported volume for ATOS is 2534310 which is 41.53% above its average volume of 1790590.

Volatility

ATOS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 8.52%, a negative 2.93%, and a positive 3.98%.

ATOS’s highest amplitude of average volatility was 11.00% (last week), 4.14% (last month), and 3.98% (last quarter).

More news about ATOS.

3. AUREA (AURE.PA)

-8.82% Price Change

Aurea SA engages in the recycling of black motor oil in France. The company is also involved in the manufacturing of remold tires from used tires and recycling rigid PVC. It recycles plastics and packaging products; refines and recycles aluminum; recycles copper and produces copper alloys; and treats and recycles zinc, lead, and cadmium. In addition, the comany engages in the treatment and decontamination of mercury waste. The company was formerly known as AUER and changed its name to Aurea SA in 1988. Aurea SA is based in Paris, France.

CAC 40 ended the session with AUREA sliding 8.82% to €4.65 on Thursday, after five successive sessions in a row of losses. CAC 40 jumped 1.13% to €7,401.35, after three sequential sessions in a row of losses, on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, AUREA has a trailing twelve months EPS of €0.74.

PE Ratio

AUREA has a trailing twelve months price to earnings ratio of 6.28. Meaning, the purchaser of the share is investing €6.28 for every euro of annual earnings.

Volume

Today’s last reported volume for AUREA is 2106 which is 25.05% above its average volume of 1684.

More news about AUREA.

4. KENMARE RESOURCES (KMR.IR)

-5.77% Price Change

Kenmare Resources plc, together with its subsidiaries, produces and sells mineral sand products in China, the rest of Asia, Europe, the United States, and internationally. It operates the Moma Titanium Minerals Mine located on the northeast coast of Mozambique. The company's products include ilmenite, rutile, and zircon; and concentrates, including secondary zircon and mineral sand concentrates. As of December 31, 2022, it had a total proved and probable ore reserves of 1,507 million tons. The company was formerly known as Kenmare Oil Exploration plc and changed its name to Kenmare Resources plc in 1987. Kenmare Resources plc was incorporated in 1972 and is headquartered in Dublin, Ireland.

ISEQ All Share ended the session with KENMARE RESOURCES falling 5.77% to €3.92 on Thursday while ISEQ All Share jumped 3.86% to €8,796.60.

Earnings Per Share

As for profitability, KENMARE RESOURCES has a trailing twelve months EPS of €1.99.

PE Ratio

KENMARE RESOURCES has a trailing twelve months price to earnings ratio of 1.97. Meaning, the purchaser of the share is investing €1.97 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.17%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Sep 21, 2023, the estimated forward annual dividend rate is 0.57 and the estimated forward annual dividend yield is 12.25%.

Volatility

KENMARE RESOURCES’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.11%, a negative 0.36%, and a positive 1.84%.

KENMARE RESOURCES’s highest amplitude of average volatility was 2.80% (last week), 1.96% (last month), and 1.84% (last quarter).

More news about KENMARE RESOURCES.

5. SEQUANA MEDICAL (SEQUA.BR)

-5.67% Price Change

Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.

BEL 20 ended the session with SEQUANA MEDICAL dropping 5.67% to €2.83 on Thursday, following the last session’s downward trend. BEL 20 slid 0.44% to €3,552.84, after three sequential sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -690.43%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SEQUANA MEDICAL’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for SEQUANA MEDICAL is 78904 which is 208.72% above its average volume of 25558.

More news about SEQUANA MEDICAL.

6. GLINTT (GLINT.LS)

-5.49% Price Change

Glintt – Global Intelligent Technologies, S.A. provides IT consulting services for banking, insurance, public administration, and utilities sectors in Portugal, Spain, and Angola. It operates through two segments: Health and Other Markets. The company engages in the sale of equipment, furniture, consumables, and robotics solutions; development of architectural projects; and design and conception of lay-out and image for pharmacies, training, equipment maintenance, and consultancy projects. It licenses proprietary software solutions for healthcare providers, such as clinics, hospitals, pharmacies, and other bodies of the ministry of health; and develops, implements, and maintains software services for the health sector. In addition, the company implements ERPs, integrates internet systems, and develops tailor-made applications services. Further, the company develops, implements, and integrates partner platforms with emphasis on the BPM, ERP, BI and mobility solutions; and integrates IT infrastructures, as well as support for networking, security, storage systems, and database management. Glintt – Global Intelligent Technologies, S.A. was incorporated in 1995 and is based in Sintra, Portugal. Glintt – Global Intelligent Technologies, S.A. operates as a subsidiary of Farminveste – Investimentos, Participações E Gestão S.A.

PSI ended the session with GLINTT sliding 5.49% to €0.34 on Thursday, following the last session’s upward trend. PSI slid 0% to €6,322.62, after five sequential sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, GLINTT has a trailing twelve months EPS of €0.04.

PE Ratio

GLINTT has a trailing twelve months price to earnings ratio of 8.6. Meaning, the purchaser of the share is investing €8.6 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.84%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

GLINTT’s EBITDA is 12.5.

Yearly Top and Bottom Value

GLINTT’s stock is valued at €0.34 at 21:40 EST, way above its 52-week high of €0.30.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 115.18M for the twelve trailing months.

More news about GLINTT.

7. AUGROS COSMETICS (AUGR.PA)

-5.41% Price Change

Augros Cosmetic Packaging SA provides customized packaging solutions in France. The company offers decoration solutions for glass, plastic, and aluminum packaging materials. It serves the perfume, cosmetic, and spirit industries. The company is based in Alencon, France. Augros Cosmetic Packaging SA operates as a subsidiary of Famille Bourgine.

CAC 40 ended the session with AUGROS COSMETICS dropping 5.41% to €7.00 on Thursday, following the last session’s upward trend. CAC 40 jumped 1.13% to €7,401.35, after three sequential sessions in a row of losses, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, AUGROS COSMETICS has a trailing twelve months EPS of €0.43.

PE Ratio

AUGROS COSMETICS has a trailing twelve months price to earnings ratio of 16.28. Meaning, the purchaser of the share is investing €16.28 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AUGROS COSMETICS’s stock is considered to be oversold (<=20).

More news about AUGROS COSMETICS.

8. CARASENT (CARA.OL)

-5.39% Price Change

Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company offers Webdoc, a digital electronic health record (EHR) system; Vårdrummet, a digital platform for communication between patients and therapists, as well as care givers; and Ad Curis, a journal and professional system that delivers forward-thinking services to rehabilitation, substance abuse treatment, and mental health care, as well as organizations within upbringing and preventive works. It also provides Metodika EPM, a solution for medium sized private clinics and hospitals; Medrave M4, a program that offers healthcare professionals with an overview of the patient treatment group; Confrere, a video solution for physicians; and Plustoo, a software solution that collects, analyses, and visualizes data, as well as enables occupational health providers, employers, and employees to collaborate for healthy and sustainable work environment. In addition, the company provides Ad Voca; and Ad Opus, a system that structures work processes to follow-up participants in a course of measures for companies that work with inclusion into working life. Carasent ASA was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. The company was founded in 1997 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with CARASENT dropping 5.39% to €12.28 on Thursday while Oslo Børs Benchmark Index_GI rose 0.41% to €1,276.39.

Earnings Per Share

As for profitability, CARASENT has a trailing twelve months EPS of kr-0.8.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.05%.

Sales Growth

CARASENT’s sales growth is 32.3% for the ongoing quarter and 19.4% for the next.

Volatility

CARASENT’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.82%, a positive 1.22%, and a positive 2.58%.

CARASENT’s highest amplitude of average volatility was 2.08% (last week), 2.89% (last month), and 2.58% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

CARASENT’s EBITDA is 2.54.

Yearly Top and Bottom Value

CARASENT’s stock is valued at kr12.28 at 21:40 EST, below its 52-week low of kr13.50.

More news about CARASENT.

9. ITERA (ITERA.OL)

-5.26% Price Change

Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ITERA falling 5.26% to €12.60 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI jumped 0.41% to €1,276.39, after three successive sessions in a row of losses, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.76.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 16.58. Meaning, the purchaser of the share is investing kr16.58 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 86.07%.

Moving Average

ITERA’s worth is above its 50-day moving average of kr11.83 and below its 200-day moving average of kr13.53.

Volume

Today’s last reported volume for ITERA is 6644 which is 79.98% below its average volume of 33187.

More news about ITERA.

10. POXEL (POXEL.PA)

-4.82% Price Change

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.

CAC 40 ended the session with POXEL dropping 4.82% to €0.42 on Thursday, following the last session’s downward trend. CAC 40 jumped 1.13% to €7,401.35, after three sequential sessions in a row of losses, on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, POXEL has a trailing twelve months EPS of €-1.08.

More news about POXEL.

Stay up to date with our winners and losers daily report